Dramatic response to dupilumab in papular amyloidosis

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1071-e1072. doi: 10.1111/jdv.18482. Epub 2022 Aug 13.

Authors

S Zahid¹, A Saussine¹, A Calugareanu¹, M Jachiet¹, M-D Vignon-Pennamen², M Rybojad¹, M Bagot¹, J-D Bouaziz^#¹, T Mahévas^#¹

Affiliations

¹ Department of Dermatology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris University, Paris, France.
² Department of Pathology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris University, Paris, France.

^# Contributed equally.

PMID: 35925832
DOI: 10.1111/jdv.18482

No abstract available

Publication types

Letter

MeSH terms

Amyloidosis*
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Skin Abnormalities*
Skin Diseases*

Substances

dupilumab
Antibodies, Monoclonal, Humanized